ImmunityBio Inc (NAS:IBRX)
$ 5.44 0.24 (4.62%) Market Cap: 3.79 Bil Enterprise Value: 4.15 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 28/100

NantKwest, Inc. - Special Call Transcript

May 27, 2020 / 04:00PM GMT
Corey Davis;LifeSci Advisors;Relationship Manager

Okay, everyone, why don't we go ahead and get started? Thanks for joining us for this Zoom call to discuss NantKwest announcement that shouldn't be out right now as they become part of Operation Warp Speed with its COVID vaccine and its new deal with ImmunityBio for a joint development, manufacturing and marketing agreement.

For those of you that don't know me, I'm Corey Davis. I'm one of the relationship managers here at LifeSci Advisors. And today, I'm very pleased to have Dr. Patrick Soon-Shiong, the Chairman and CEO of both NantKwest and ImmunityBio. In a second, I'll turn it over to Patrick. Hopefully, he'll be ready in a second to walk through several slides to present some of the main points of what differentiates the science that they've got at NantKwest in their COVID program.

Then we'll use, after the slides, a more typical fireside chat program. I'll pose some questions to Patrick, mostly around what differentiates their vaccine program and also touch on a few other things going on with the company.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot